Why Is Buffett Buying Verisign?
Warren Buffett has spent 2024 stockpiling cash, even going so…
Buy
55
IMRX Quote, Financials, Valuation and Earnings
Last price:
$2.25
Seasonality move
:
2.94%
Day range:
$2.14 - $2.39
52-week range:
$1.00 - $7.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
217.13x
P/B ratio:
1.25x
Volume:
341.3K
Avg. volume:
728.3K
1-year change:
-68.51%
Market cap:
$72.3M
Revenue:
--
EPS (TTM):
-$1.97
Earnings Data
Next earnings date for IMRX
Feb 28
2025
Most recent earnings per share
-$0.49
Beat by $0.06
(Nov 13/2024)
Consensus Estimate
-$0.55
(Nov 13/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IMRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/28/2025 | Q4 | -- | -- | -- | -$0.39 | -- |
| 11/13/2024 | Q3 | -- | -- | -$0.49 | -$0.55 | $0.06 |
| 08/06/2024 | Q2 | -- | -- | -$0.47 | -$0.53 | $0.06 |
| 05/07/2024 | Q1 | -- | -- | -$0.49 | -$0.50 | $0.01 |
| 03/01/2024 | Q4 | -- | -- | -$0.52 | -$0.48 | -$0.04 |
| 11/09/2023 | Q3 | -- | -- | -$0.43 | -$0.49 | $0.06 |
| 08/03/2023 | Q2 | -- | -- | -$0.43 | -$0.53 | $0.10 |
| 05/04/2023 | Q1 | -- | -- | -$0.51 | -$0.56 | $0.05 |
| 03/06/2023 | Q4 | -- | -- | -$0.50 | -$0.56 | $0.06 |
| 11/10/2022 | Q3 | -- | -- | -$0.49 | -$0.48 | -$0.01 |
| 08/10/2022 | Q2 | -- | -- | -$0.44 | -- | -- |
| 05/10/2022 | Q1 | -- | -- | -$0.49 | -- | -- |
| 03/10/2022 | Q4 | -- | -- | -$0.42 | -- | -- |
| 11/09/2021 | Q3 | -- | -- | -$0.47 | -- | -- |
| 09/09/2021 | Q2 | -- | -- | -$0.33 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.46 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.43 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.33 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.27 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.24 | -- | -- |
Immuneering Earnings Questions
-
How Much did Immuneering Generate in Revenue Last Quarter?
Immuneering reported -- worth of top line sales in its most recent quarter.
-
Did Immuneering Beat Earnings Last Quarter?
Immuneering announced earnings per share of -$0.49 which represents a beat of analyst forecast a -$0.55 per share.
-
Is Immuneering Profitable?
Immuneering reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Immuneering EPS Next Year?
Immuneering's earnings are forecast to decrease from -$1.88 per share to -$1.85 per share next year representing a decrease of -4.61%.
-
When is Immuneering's Earnings Date?
Immuneering's next earnings date is February 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Microsoft an Undervalued Growth Stock to Buy?
Tech giant Microsoft (NASDAQ:MSFT) has been one of the biggest…
Will Tesla Go Up or Down in 2025?
The last few months have been exciting for Tesla and…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 30
Lemonade [LMND] is down 2.82% over the past day.
Buy
63
SMLR alert for Dec 30
Semler Scientific [SMLR] is down 11.17% over the past day.
Sell
39
DOGZ alert for Dec 30
Dogness (International) [DOGZ] is up 3.61% over the past day.
